Lifecore Biomedical, Inc. De (LFCR) Consolidated Net Income (2010 - 2025)

Lifecore Biomedical has reported Consolidated Net Income for 16 years, with the latest figure at -$15.9 million in Q2 2025.

• On a quarterly basis, Consolidated Net Income fell 124.82% year-over-year to -$15.9 million in Q2 2025; TTM through May 2025 was -$53.5 million, a 545.3% decrease from a year earlier, with the FY2025 full-year figure at -$38.7 million, down 422.29% from the prior year.
• Consolidated Net Income was -$15.9 million for Q2 2025 at Lifecore Biomedical, down from -$14.8 million in the prior quarter.
• The five-year high for Consolidated Net Income was $15.6 million in Q1 2024, with the low at -$55.7 million in Q2 2022.
• Average Consolidated Net Income over 5 years is -$15.9 million, with a median of -$13.8 million recorded in 2022.
• The sharpest annual moves came in 2022 and 2023: Consolidated Net Income tumbled 233.13% in 2022, then jumped 211.03% in 2023.
• Over 5 years, Consolidated Net Income stood at -$38.5 million in 2021, then jumped by 66.71% to -$12.8 million in 2022, then surged by 211.03% to $14.2 million in 2023, then sank by 146.22% to -$6.6 million in 2024, then tumbled by 142.34% to -$15.9 million in 2025.
• The last three Consolidated Net Income figures came in at -$15.9 million (Q2 2025), -$14.8 million (Q1 2025), and -$6.6 million (Q4 2024), per Business Quant data.